Re: Sulfonylureas as second line drugs in type 2 diabetes and the risk of cardiovascular and hypoglycaemic events: population based cohort study
Source: BMJ Comments - Category: General Medicine Source Type: forums
More News: Cardiology | Cardiovascular | Diabetes | Diabetes Type 2 | Endocrinology | General Medicine | Heart | Study